Thytech logo

Thytech

THYTECH is a health tech spin-off offering cellular therapy for immune disorders, transplants, autoimmune diseases, and COVID.

2-10 employees · est. 2022

VS
TolerogenixX GmbH logo

TolerogenixX GmbH

The Smart Way to Immune Tolerance

3 employees · est. 2016 · Heidelberg, Germany

TolerogenixX GmbH is the older company (2022 vs 2016).

Side-by-Side Comparison

Thytech TolerogenixX GmbH
Founded
2022 2016 older
Headquarters
Not tracked yet Heidelberg, Germany
Employees
2-10 3
Industry
Health Care Not tracked yet
Funding Stage
Pre Seed Series A
Total Funding
$350.00K $11.10M
Funding Rounds
1 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Health Tech, Cellular Therapy, Immune Disorders, Transplants, Autoimmune Diseases, COVID, Patented Technologies, ThyTreg Cell Therapy, Transplant Rejection, Immunological Balance, Childhood Illnesses, Inmunología, Terapias Celulares Avanzadas, Investigación Biomédica Immunosuppression, ATMP, MIC Cell Treatment, Transplantation, Autoimmune Diseases, SLE, Biotech, Medtech, Investment, Pre-clinical Data, Clinical Data, High-Tech Gründerfonds, Technology-driven Companies, Seed Stage Investor, Germany
Website
inmunoregulacion.es tolerogenixx.com
Thytech logo

About Thytech

Thytech is a health tech startup that spun off from the Gregorio Marañón Health Research Institute (IISGM), specializing in cellular therapy for a range of health issues including immune disorders, transplants, autoimmune diseases, and COVID. Emerging from the Immunoregulation Laboratory's research,...

TolerogenixX GmbH logo

About TolerogenixX GmbH

TolerogenixX GmbH is a German-based startup founded in 2016 with the slogan "The Smart Way to Immune Tolerance." The company focuses on innovating immunosuppression through its newly developed MIC Cell Treatments. These treatments aim to achieve sustained regulation of the immune system in transplan...

We will tell you when either one moves

BounceWatch watches Thytech and TolerogenixX GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Thytech and TolerogenixX GmbH — by email.

Frequently Asked Questions

Thytech — THYTECH is a health tech spin-off offering cellular therapy for immune disorders, transplants, autoimmune diseases, and COVID.. TolerogenixX GmbH — The Smart Way to Immune Tolerance . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Thytech has raised $350.00K while TolerogenixX GmbH has raised $11.10M.
Thytech and TolerogenixX GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Thytech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Thytech on 11 Sep 2024, and TolerogenixX GmbH on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy